Supplementary
++ high conventional DCs were gated, (F) DC doublets were excluded, (G) CD141 -CD16 -DC were gated, which showed CD1c + positivity (H). After sorting, CD1c + cells were recalled verifying the purity of sorting (I). The antibodies used in the sorting are described in the Methods section. -/-(n=14) mice were sensitized according to the protocol described in Methods. Mice were monitored for disease onset and paw swelling from day 10. Mice were culled on day 33 and serum harvested. The titres of anticollagen IgG1 and IgG2a antibodies were evaluated with specific biotin-labelled anti-IgG1 and anti-IgG2a antibodies. Sera were serially diluted as indicated on the graph. Two-way Anova test demonstrated no difference in the antibody response between the genotypes. -/-mice (n=3, pooled) were cultured with GM-CSF (20 ng/ml). After 3 and 6 days the medium was replaced with fresh medium supplemented with GM-CSF. At day 8, the purity of the DCs was evaluated by FACS (A) and then cells were stimulated with LPS (1 ng/ml) for 48h (B) -/-mice (n=3 pooled) were cultured with GM-CSF (20 ng/ml). After 3 and 6 days, the medium was replaced with fresh medium supplemented with GM-CSF. At day 8, the purity of DCs was evaluated by FACS (as shown in sup. Fig. 5A ) and cells were stimulated with LPS (1 ng/ml) or CL097 (1 µg/ml) for 48h and the expression of adhesion molecules CD11b, CD11c, CD18 and ICAM-1 evaluated by flow cytometry mean fluorescent index (MFI) was no different between the genotypes. Data are presented as mean ± s.e.m of 4-8 replicates from 2 independent experiments; *p<0.05, Kruskal Wallis test and Dunn's multiple comparison test. -/-mice (n=3, pooled) were cultured with GM-CSF (20 ng/ml). After 3 and 6 days, the medium was replaced with fresh medium supplemented with GM-CSF. At day 8, cells were stimulated with LPS (1 ng/ml) or CL097 (1 µg/ml) for 48h; and supernatant TNF and IL-6, quantified by enzyme-immunoassay, was significant increased in Axl -/-DC cultures (A), and surface expression of MHC class II quantified by flow cytometry mean fluorescent index (MFI) was significant increased in Axl were evaluated in sera of the study cohort described in Supplementary Table 3 . Compared to healthy donors, sAXL was significantly increased in RA patients naïve to treatment (**p<0.001) and in RA patients resistant to treatment (*p<0.01), Kruskal Wallis test with Dunn's multiple comparison. DAS28, disease activities score that includes 28 joints. RA Naïve to treatment = RA patients naïve to any Disease-Modifying Anti-Rheumatic Drugs (DMARDs); RA in remission = RA patients in stable remission achieved under combination therapy of Methotrexate + TNF inhibitor; RA resistant to treatment = RA patients not responding to conventional DMARDs/biologic treatments. The DAS scores in parentheses are the mean values for the groups.
